HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Modulation of pulmonary blood flow in patients with acute respiratory failure.

AbstractBACKGROUND:
Impairment of ventilation and perfusion (V/Q) matching is a common mechanism leading to hypoxemia in patients with acute respiratory failure requiring intensive care unit (ICU) admission. While ventilation has been thoroughly investigated, little progress has been made to monitor pulmonary perfusion at the bedside and treat impaired blood distribution. The study aimed to assess real-time changes in regional pulmonary perfusion in response to a therapeutic intervention.
METHODS:
Single-center prospective study that enrolled adult patients with ARDS caused by SARS-Cov-2 who were sedated, paralyzed, and mechanically ventilated. The distribution of pulmonary perfusion was assessed through electrical impedance tomography (EIT) after the injection of a 10-ml bolus of hypertonic saline. The therapeutic intervention consisted in the administration of inhaled nitric oxide (iNO), as rescue therapy for refractory hypoxemia. Each patient underwent two 15-min steps at 0 and 20 ppm iNO, respectively. At each step, respiratory, gas exchange, and hemodynamic parameters were recorded, and V/Q distribution was measured, with unchanged ventilatory settings.
RESULTS:
Ten 65 [56-75] years old patients with moderate (40%) and severe (60%) ARDS were studied 10 [4-20] days after intubation. Gas exchange improved at 20 ppm iNO (PaO2/FiO2 from 86 ± 16 to 110 ± 30 mmHg, p = 0.001; venous admixture from 51 ± 8 to 45 ± 7%, p = 0.0045; dead space from 29 ± 8 to 25 ± 6%, p = 0.008). The respiratory system's elastic properties and ventilation distribution were unaltered by iNO. Hemodynamics did not change after gas initiation (cardiac output 7.6 ± 1.9 vs. 7.7 ± 1.9 L/min, p = 0.66). The EIT pixel perfusion maps showed a variety of patterns of changes in pulmonary blood flow, whose increase positively correlated with PaO2/FiO2 increase (R2 = 0.50, p = 0.049).
CONCLUSIONS:
The assessment of lung perfusion is feasible at the bedside and blood distribution can be modulated with effects that are visualized in vivo. These findings might lay the foundations for testing new therapies aimed at optimizing the regional perfusion in the lungs.
AuthorsStefano Spina, Francesco Marrazzo, Caio C A Morais, Marcus Victor, Clarissa Forlini, Marcello Guarnieri, Luca Bastia, Riccardo Giudici, Gabriele Bassi, Yi Xin, Maurizio Cereda, Marcelo Amato, Thomas Langer, Lorenzo Berra, Roberto Fumagalli
JournalNitric oxide : biology and chemistry (Nitric Oxide) Vol. 136-137 Pg. 1-7 (07 01 2023) ISSN: 1089-8611 [Electronic] United States
PMID37172929 (Publication Type: Journal Article)
CopyrightCopyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.
Chemical References
  • Nitric Oxide
Topics
  • Adult
  • Humans
  • Middle Aged
  • Aged
  • Pulmonary Circulation
  • Prospective Studies
  • Pulmonary Gas Exchange
  • COVID-19 (complications)
  • SARS-CoV-2
  • Respiratory Distress Syndrome (drug therapy, etiology)
  • Nitric Oxide
  • Hypoxia
  • Respiratory Insufficiency (drug therapy)
  • Administration, Inhalation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: